Network origin in Taro Tokita first degree
Entity | Entity type | Industry | |
---|---|---|---|
SMBC Venture Capital KK
SMBC Venture Capital KK Investment ManagersFinance SMBC Venture Capital KK (SMBC Venture Capital) is a Private Equity firm, a subsidiary of Sumitomo Mitsui Banking Corp., itself a subsidiary of publicly traded company Sumitomo Mitsui Financial Group, Inc. (TK:8316) founded in 2005. The firm is headquartered in Tokyo.
7
| Subsidiary | Investment Managers | 7 |
ARTham Therapeutics, Inc.
ARTham Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Kaken Pharmaceutical Co., Ltd., ARTham Therapeutics, Inc. is a pharmaceutical company based in Yokohama, Japan. The Japanese company's mission is to deliver "medicines that matter" to improve patient health and contribute to enhanced quality of life through the development of innovative disease-modifying medicines. The company was founded by Sham Nikam, Naoto Uemura, and has been led by CEO Hiroshi Nagabukuro since 2018. ARTham Therapeutics was acquired by Kaken Pharmaceutical Co., Ltd. on December 13, 2021 for $111.95 million.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
RBG Partners KK
RBG Partners KK Investment ManagersFinance RBG Partners KK engages in the operation and management of investment business partnership assets. It also deals with the acquisition and holding of securities and offers consulting services for company diagnosis and investment planning. The company was founded on October 2, 2018 and is headquartered in Yokohama, Japan.
2
| Private Company | Investment Managers | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Taro Tokita via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
SEGA SAMMY HOLDINGS INC. | Packaged Software | Director/Board Member | |
Sumitomo Mitsui Banking Corp.
Sumitomo Mitsui Banking Corp. Major BanksFinance Sumitomo Mitsui Banking Corp. engages in the provision of financial services centered on banking. It operates through the following business segments: Wholesale, Retail, International, Market Sales, and Headquarters Management. The Wholesale segment covers business for customers of large and medium-sized companies in Japan. The Retail segment handles business for domestic individuals and SME customers. The International segment comprises of business for overseas Japanese and non-Japanese companies. The Market Sales segment corresponds to financial market business. The Headquarters Management segment includes all other businesses not covered by other segments. The company was founded in April 2001 and is headquartered in Tokyo, Japan. | Major Banks | Corporate Officer/Principal | |
Ginsen Co., Ltd.
Ginsen Co., Ltd. Insurance Brokers/ServicesFinance Ginsen Co., Ltd. engages in the general insurance agency, life insurance agency, building, parking lots and real estate consulting businesses. The company was founded in May 1954 and is headquartered in Osaka, Japan. | Insurance Brokers/Services | President | |
JAPAN ASIA INVESTMENT CO., LTD. | Investment Managers | Corporate Officer/Principal | |
ELECOM CO., LTD. | Computer Peripherals | Director/Board Member | |
DX Antenna Co., Ltd.
DX Antenna Co., Ltd. Telecommunications EquipmentElectronic Technology DX Antenna Co. Ltd. manufactures antenna and other networking equipment. The firm’s products include optical transmitters/receivers, BS antennas, CS antennas, CS/BS multi-beam antennas, wireless LAN antennas, CS/BS receivers, headend devices, two way CATV amplifiers, channel proper amplifiers, converters, level controllers, UHF antennas, VHF antennas, FM antennas, amateur radio antennas, and mixer/band separators. The company was founded on August 1, 1953 and is headquartered in Kobe-shi, Japan. | Telecommunications Equipment | Director/Board Member | |
Saitama University | College/University | Doctorate Degree | |
Kobe University | College/University | Undergraduate Degree | |
Takeda Ventures, Inc.
Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures Inc (Takeda Ventures) is a venture capital subsidiary of Takeda America Holdings Inc founded in 2001. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
Sidney Kimmel Medical College | College/University | Doctorate Degree | |
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
Singapore Management University | College/University | Graduate Degree | |
WITH Corp.
WITH Corp. Electronic Equipment/InstrumentsElectronic Technology WITH Corp. engages in development, publishing, and distribution of audio books, educational toys, and promotional products. It also engages in the plan, manufacture and module process of electronic components. The company was founded on June 21, 1976 and is headquartered in Tokyo, Japan. | Electronic Equipment/Instruments | Director/Board Member | |
Almex PE, Inc.
Almex PE, Inc. Engineering & ConstructionIndustrial Services Almex PE, Inc. provides engineering and maintenance services for surface treatment equipment. It also manufactures and distributes chemical products. The company was founded in June 1966 and is headquartered in Kanuma, Japan. | Engineering & Construction | Director/Board Member | |
Whiz Partners, Inc.
Whiz Partners, Inc. Investment ManagersFinance Whiz Partners, Inc. (Whiz Partners) is an independent venture capital firm headquartered in Tokyo, Japan. It became a separate entity from its former brand, CSK Venture Capital Co., Ltd. The firm was founded by Toshio Ando, Atsushi Matsumura, and Junichi Kajimoto in 2010. | Investment Managers | Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin | |
Miyako Capital KK
Miyako Capital KK Investment ManagersFinance Miyako Capital KK (Miyako Capital) is an Independent Private Equity/Venture Capital firm founded in 2013 by Satoshi Yamaguchi and Hiroaki Okahashi. Miyako Capital KK is headquartered in Kyoto. | Investment Managers | Private Equity Investor | |
SHATTUCK LABS, INC. | Biotechnology | Director/Board Member | |
CellAxia, Inc.
CellAxia, Inc. Pharmaceuticals: MajorHealth Technology CellAxia, Inc. is a Japanese company that engages in research and development, manufacturing, and selling of pharmaceutical products. The company is based in Tokyo, Japan. The company was founded in 2017 by Makoto Seki. | Pharmaceuticals: Major | Director/Board Member | |
Adaptate Biotherapeutics Ltd.
Adaptate Biotherapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Adaptate Biotherapeutics Ltd. engages in research and experimental development on biotechnology. The company was founded on August 21, 2019 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
IgniteEye Corp.
IgniteEye Corp. Packaged SoftwareTechnology Services IgniteEye Corp. engages in the provision of cloud services for recruitment activities. Its cloud products include SONAR, Compass, Sniping and CREATIVE. The company was founded by Takashi Yoshida in May 2013 and is headquartered in Tokyo, Japan. | Packaged Software | Director/Board Member | |
Axcelead Drug Discovery Partners, Inc.
Axcelead Drug Discovery Partners, Inc. Miscellaneous Commercial ServicesCommercial Services Axcelead Drug Discovery Partners, Inc. is a Japanese company founded in 2017 that provides services for the quality evaluation of new modality regenerative medical cells, effectiveness and safety evaluation of target cells, and bridging data. The company is based in Fujisawa, JP. and has subsidiaries in the United States. It is used by more than 100 facilities such as clients pharmaceutical companies, venture companies, and academia. Axcelead offers non-clinical development strategic planning and problem resolution services to its clients. | Miscellaneous Commercial Services | Director/Board Member | |
Iron City Micro Display, Inc. | Director/Board Member | ||
Code Biotherapeutics, Inc.
Code Biotherapeutics, Inc. BiotechnologyHealth Technology Code Biotherapeutics, Inc. is a next-generation gene therapy company based in Greater Philadelphia. The American company is focused on developing targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. The company uses a novel multivalent synthetic DNA delivery platform called 3DNA, which overcomes many of the challenges associated with viral-based gene therapies. Code Biotherapeutics is advancing an internal pipeline focused on select rare disease programs and establishing partnerships to take forward programs in both rare and prevalent diseases. Code Biotherapeutics is supported by top-tier investors that believe in their work to drive discovery programs forward as they aim to deliver on the promise of their proprietary synthetic DNA-based, non-viral genetic medicines delivery platform. The company was founded by Brian P. McVeigh, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
82VS | Investment Managers | President |
Statistics
International
Japan | 20 |
United States | 8 |
United Kingdom | 2 |
Sectoral
Finance | 10 |
Consumer Services | 6 |
Electronic Technology | 5 |
Health Technology | 5 |
Technology Services | 3 |
Operational
Director/Board Member | 21 |
Private Equity Investor | 7 |
President | 5 |
Corporate Officer/Principal | 4 |
Independent Dir/Board Member | 3 |
Most connected contacts
- Stock Market
- Insiders
- Taro Tokita
- Company connections